XML 44 R32.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Share Based Compensation (Tables)
 6 Months Ended
Jun. 30, 2024
Share Based Compensation [Abstract]  
Schedule of Activity with Respect to, and Status of, RSUs A summary of the activity with respect to, and status of, RSUs during the three and six-month period ended June 30, 2024 is presented below:
   Number of
RSUs		   Weighted
Average Grant
Date Value		 
Unvested as of January 1, 2024   1,655,542   $9.61 
Granted   2,276,710    8.10 
Forfeited   (108,000)   10.12 
Vested   (638,629)   6.91 
Unvested as of March 31, 2024   3,185,623   $8.93 
Granted   490,140    3.48 
Forfeited   (5,000)   10.12 
Vested   (642,204)   6.44 
Unvested as of June 30, 2024   3,028,559   $6.65 
Schedule of Common Stock and Current Interest Rates The fair value of the earnout shares was estimated using a Monte Carlo simulation utilizing assumptions related to the contractual term of the instruments, estimated volatility of the price of the Common Stock and current interest rates. Below are the key assumptions used in valuing the earnout shares:
   As of
7/19/2023		 
PSQH Stock Price  $9.08 
Volatility   40.0%
Risk free rate of return   4.6%
Expected term (in years)   4.8 years 
Schedule of Share-Based Compensation Expense During the three and six months ended June 30, 2024, the Company recorded the following share-based compensation expense, related to RSUs, earnout shares and Credova Merger:
   For the   For the 
   three months   six months 
   ended   ended 
   June 30,   June 30, 
   2024   2024 
Cost of sales  $56,011   $79,985 
General and administrative expenses   3,217,865    5,855,998 
Research and development   416,871    737,986 
Sales and marketing   1,481,014    3,496,807 
Transaction costs incurred in connection with Credova Merger   
-
    887,409 
   $5,171,761   $11,058,185